Status:
COMPLETED
Scan-Rescan Sub-Study of MS PATHS
Lead Sponsor:
Biogen
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
21-55 years
Brief Summary
The primary objective of this sub-study is to calculate the reproducibility and other technical performance measures of various magnetic resonance imaging (MRI) image analysis algorithms in order to a...
Eligibility Criteria
Inclusion
- Key
- Participants (or participant's legal representative) has the ability to understand the purpose and risks of the sub-study and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and l local participant privacy regulations.
- Diagnosis of relapse-onset MS (relapsing-remitting or secondary progressive).
- First MS symptom within the past 1 to 30 years.
- Key
Exclusion
- Initiation of any MS disease-modifying treatment within 4 weeks prior to Visit 1.
- Steroid treatment or suspected MS relapse within 6 weeks prior to Visit 1.
- Note: Other protocol specified inclusion and exclusion criteria may apply.
Key Trial Info
Start Date :
February 11 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 9 2017
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04123353
Start Date
February 11 2017
End Date
May 9 2017
Last Update
October 10 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Baltimore, Maryland, United States, 21205
2
Research Site
New York, New York, United States, 10016
3
Research Site
Cleveland, Ohio, United States, 44195